Drug  	Drug  	 NN	B-NP
repositioning  	repositioning  	 NN	I-NP
approaches  	approaches  	 NNS	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
discovery  	discovery  	 NN	O
of  	of  	 IN	O
new  	new  	 JJ	O
therapeutics  	therapeutics  	 NN	O
for  	for  	 IN	O
Alzheimer 	Alzheimer 	 NNP	O
's  	's  	 POS	O
disease  	disease  	 NN	B-NP
Alzheimer 	Alzheimer 	 NNP	I-NP
's  	's  	 POS	I-NP
disease  	disease  	 NN	O
( 	( 	 -LRB-	O
AD 	AD 	 NNP	O
)  	)  	 -RRB-	O
is  	is  	 VBZ	O
the  	the  	 DT	O
most  	most  	 RBS	O
common  	common  	 JJ	O
cause  	cause  	 NN	O
of  	of  	 IN	O
dementia  	dementia  	 NN	B-NP
and  	and  	 CC	O
represents  	represents  	 VBZ	O
one  	one  	 CD	O
of  	of  	 IN	O
the  	the  	 DT	O
highest  	highest  	 JJS	O
unmet  	unmet  	 JJ	O
needs  	needs  	 NNS	O
in  	in  	 IN	O
medicine  	medicine  	 NN	B-NP
today 	today 	 NN	I-NP
.  	.  	 .	O
Drug  	Drug  	 NN	B-NP
development  	development  	 NN	I-NP
efforts  	efforts  	 NNS	I-NP
for  	for  	 IN	O
AD  	AD  	 NNP	O
have  	have  	 VBP	O
been  	been  	 VBN	O
encumbered  	encumbered  	 VBN	O
by  	by  	 IN	O
largely  	largely  	 RB	O
unsuccessful  	unsuccessful  	 JJ	O
clinical  	clinical  	 JJ	B-NP
trials  	trials  	 NNS	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
last  	last  	 JJ	O
decade 	decade 	 NN	O
.  	.  	 .	O
Drug  	Drug  	 NN	B-NP
repositioning 	repositioning 	 NN	I-NP
,  	,  	 ,	O
a  	a  	 DT	O
process  	process  	 NN	O
of  	of  	 IN	O
discovering  	discovering  	 VBG	O
a  	a  	 DT	O
new  	new  	 JJ	O
therapeutic  	therapeutic  	 JJ	B-NP
use  	use  	 NN	I-NP
for  	for  	 IN	I-NP
existing  	existing  	 VBG	I-NP
drugs  	drugs  	 NNS	I-NP
or  	or  	 CC	O
drug  	drug  	 NN	B-NP
candidates 	candidates 	 NNS	I-NP
,  	,  	 ,	O
is  	is  	 VBZ	O
an  	an  	 DT	O
attractive  	attractive  	 JJ	O
and  	and  	 CC	O
timely  	timely  	 JJ	O
drug  	drug  	 NN	B-NP
development  	development  	 NN	I-NP
strategy  	strategy  	 NN	I-NP
especially  	especially  	 RB	O
for  	for  	 IN	O
AD 	AD 	 NNP	O
.  	.  	 .	O
Compared  	Compared  	 VBN	O
with  	with  	 IN	O
traditional  	traditional  	 JJ	O
de  	de  	 FW	B-NP
novo  	novo  	 FW	I-NP
drug  	drug  	 NN	I-NP
development 	development 	 NN	I-NP
,  	,  	 ,	O
time  	time  	 NN	O
and  	and  	 CC	O
cost  	cost  	 NN	O
are  	are  	 VBP	O
reduced  	reduced  	 VBN	O
as  	as  	 IN	O
the  	the  	 DT	O
safety  	safety  	 NN	O
and  	and  	 CC	O
pharmacokinetic  	pharmacokinetic  	 JJ	B-NP
properties  	properties  	 NNS	I-NP
of  	of  	 IN	O
most  	most  	 RBS	O
repositioning  	repositioning  	 JJ	B-NP
candidates  	candidates  	 NNS	I-NP
have  	have  	 VBP	O
already  	already  	 RB	O
been  	been  	 VBN	O
determined 	determined 	 VBN	O
.  	.  	 .	O
A  	A  	 DT	O
majority  	majority  	 NN	O
of  	of  	 IN	O
drug  	drug  	 NN	B-NP
repositioning  	repositioning  	 NN	I-NP
efforts  	efforts  	 NNS	I-NP
for  	for  	 IN	O
AD  	AD  	 NNP	O
have  	have  	 VBP	O
been  	been  	 VBN	O
based  	based  	 VBN	O
on  	on  	 IN	O
positive  	positive  	 JJ	B-NP
clinical  	clinical  	 JJ	I-NP
or  	or  	 CC	O
epidemiological  	epidemiological  	 JJ	B-NP
observations  	observations  	 NNS	I-NP
or  	or  	 CC	O
in  	in  	 IN	O
vivo  	vivo  	 JJ	B-NP
efficacy  	efficacy  	 NN	I-NP
found  	found  	 VBD	O
in  	in  	 IN	O
mouse  	mouse  	 NN	O
models  	models  	 NNS	O
of  	of  	 IN	O
AD 	AD 	 NNP	O
.  	.  	 .	O
More  	More  	 RBR	O
systematic 	systematic 	 JJ	O
,  	,  	 ,	O
multidisciplinary  	multidisciplinary  	 JJ	B-NP
approaches  	approaches  	 NNS	I-NP
will  	will  	 MD	O
further  	further  	 RB	O
facilitate  	facilitate  	 VB	O
drug  	drug  	 NN	B-NP
repositioning  	repositioning  	 NN	I-NP
for  	for  	 IN	O
AD 	AD 	 NNP	O
.  	.  	 .	O
Some  	Some  	 DT	O
experimental  	experimental  	 JJ	B-NP
approaches  	approaches  	 NNS	I-NP
include  	include  	 VBP	O
unbiased  	unbiased  	 JJ	O
phenotypic  	phenotypic  	 NNS	B-NP
screening  	screening  	 VBP	O
using  	using  	 VBG	O
the  	the  	 DT	O
library  	library  	 NN	B-NP
of  	of  	 IN	O
available  	available  	 JJ	O
drug  	drug  	 NN	B-NP
collections  	collections  	 NNS	I-NP
in  	in  	 IN	O
physiologically  	physiologically  	 JJ	B-NP
relevant  	relevant  	 JJ	I-NP
model  	model  	 NN	I-NP
systems  	systems  	 NNS	I-NP
( 	( 	 -LRB-	O
e.g.  	e.g.  	 NNP	O
stem  	stem  	 VBP	O
cell-derived  	cell-derived  	 JJ	O
neurons  	neurons  	 NN	B-NP
or  	or  	 CC	O
glial  	glial  	 JJ	B-NP
cells 	cells 	 NNS	I-NP
) 	) 	 -RRB-	O
,  	,  	 ,	O
computational  	computational  	 JJ	B-NP
prediction  	prediction  	 NN	I-NP
and  	and  	 CC	O
selection  	selection  	 NN	B-NP
approaches  	approaches  	 NNS	I-NP
that  	that  	 IN	O
leverage  	leverage  	 NN	O
the  	the  	 DT	O
accumulating  	accumulating  	 JJ	O
data  	data  	 NNS	O
resulting  	resulting  	 VBG	O
from  	from  	 IN	O
RNA  	RNA  	 NNP	B-NP
expression  	expression  	 NN	I-NP
profiles 	profiles 	 NNS	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
genome-wide  	genome-wide  	 JJ	B-NP
association  	association  	 NN	I-NP
studies 	studies 	 NNS	I-NP
.  	.  	 .	O
This  	This  	 DT	O
review  	review  	 NN	O
will  	will  	 MD	O
summarize  	summarize  	 VB	O
several  	several  	 JJ	O
notable  	notable  	 JJ	O
strategies  	strategies  	 NNS	O
and  	and  	 CC	O
representative  	representative  	 JJ	B-NP
examples  	examples  	 NNS	I-NP
of  	of  	 IN	I-NP
drug  	drug  	 NN	I-NP
repositioning  	repositioning  	 NN	I-NP
for  	for  	 IN	O
AD 	AD 	 NNP	O
.  	.  	 .	O
